Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 27% ± 10% | |
| astrocyte | 4 studies | 33% ± 13% | |
| GABAergic neuron | 3 studies | 36% ± 5% | |
| glutamatergic neuron | 3 studies | 41% ± 2% | |
| Schwann cell | 3 studies | 22% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 31% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 1104.21 | 236 / 245 | 90% | 5.15 | 452 / 502 |
| esophagus | 87% | 1346.19 | 1250 / 1445 | 76% | 3.33 | 139 / 183 |
| pancreas | 95% | 851.05 | 311 / 328 | 56% | 2.20 | 99 / 178 |
| brain | 63% | 288.71 | 1659 / 2642 | 85% | 11.61 | 596 / 705 |
| stomach | 99% | 1355.81 | 356 / 359 | 47% | 1.68 | 135 / 286 |
| bladder | 90% | 748.19 | 19 / 21 | 53% | 2.32 | 267 / 504 |
| intestine | 98% | 2166.19 | 947 / 966 | 45% | 1.60 | 239 / 527 |
| kidney | 99% | 735.47 | 88 / 89 | 21% | 0.53 | 185 / 901 |
| adrenal gland | 79% | 390.93 | 203 / 258 | 38% | 2.79 | 88 / 230 |
| lung | 46% | 220.13 | 266 / 578 | 66% | 3.69 | 768 / 1155 |
| breast | 69% | 484.93 | 316 / 459 | 35% | 1.33 | 395 / 1118 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.70 | 1 / 1 |
| thymus | 68% | 282.23 | 441 / 653 | 19% | 0.77 | 114 / 605 |
| muscle | 81% | 776.46 | 651 / 803 | 0% | 0 | 0 / 0 |
| uterus | 52% | 318.89 | 88 / 170 | 25% | 1.09 | 114 / 459 |
| skin | 62% | 303.54 | 1117 / 1809 | 13% | 0.75 | 60 / 472 |
| ovary | 47% | 194.37 | 85 / 180 | 20% | 0.71 | 86 / 430 |
| heart | 65% | 485.45 | 562 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 37% | 211.79 | 494 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 30% | 149.79 | 367 / 1204 | 0% | 0 | 0 / 0 |
| liver | 6% | 17.23 | 14 / 226 | 11% | 0.30 | 43 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 13% | 0.29 | 6 / 45 |
| spleen | 1% | 2.78 | 3 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.33 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0007155 | Biological process | cell adhesion |
| GO_0005604 | Cellular component | basement membrane |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005588 | Cellular component | collagen type V trimer |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0008201 | Molecular function | heparin binding |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
| Gene name | COL28A1 |
| Protein name | Collagen type XXVIII alpha 1 chain Collagen alpha-1(XXVIII) chain |
| Synonyms | COL28 |
| Description | FUNCTION: May act as a cell-binding protein. |
| Accessions | A0A0C4DG66 H7BZU0 ENST00000444268.1 H7C3P2 ENST00000430711.5 Q2UY09 ENST00000453441.1 ENST00000399429.8 [Q2UY09-1] ENST00000435823.1 A0A0C4DG72 |
